Treatment of Trichomoniasis
The first-line treatment for trichomoniasis is oral metronidazole 2g as a single dose, with cure rates of approximately 90-95%. 1, 2
First-Line Treatment Options
- Metronidazole 2g orally in a single dose is the recommended first-line treatment for trichomoniasis in both males and females 1, 2
- An alternative regimen is metronidazole 500mg orally twice daily for 7 days, which may be considered when medication adherence is not a concern 1, 3
- Recent evidence suggests that the 7-day regimen may be more effective than single-dose therapy (11% vs 19% treatment failure rates) 4
- Tinidazole is an FDA-approved alternative that can be used for trichomoniasis treatment 5
Management of Sexual Partners
- All sexual partners should be treated simultaneously to prevent reinfection 1, 3
- Patients should abstain from sexual activity until both they and their partners complete treatment and are asymptomatic 6, 3
- Asymptomatic partners should be treated even if diagnostic testing is negative or not performed, as they may still harbor the infection 2
Follow-Up Recommendations
- Routine follow-up is unnecessary for patients who become asymptomatic after treatment 3
- If symptoms persist after treatment, consider reinfection or resistant infection 6, 3
Treatment Failure Management Algorithm
For first treatment failure:
For second treatment failure:
- Administer metronidazole 2g once daily for 3-5 days 3
For persistent failure:
Important Clinical Considerations
- Topical metronidazole gel is NOT effective for trichomoniasis (efficacy <50%) and should not be used 3, 1
- Metronidazole can cause a disulfiram-like reaction when combined with alcohol, which may include nausea, vomiting, flushing, headache, and abdominal cramps 6
- Patients should be advised to avoid alcohol during treatment and for at least 24 hours after completing metronidazole therapy 6
- Common side effects include nausea (23%), headache (7%), and vomiting (4%) 4
Special Situations
Pregnancy
- Metronidazole 2g single dose is recommended for symptomatic pregnant women after the first trimester 3, 6
- Multiple studies have not demonstrated consistent association between metronidazole use during pregnancy and teratogenic effects 3
Metronidazole Allergy
- For patients with an immediate-type allergy to metronidazole, desensitization may be required 3
- Topical therapy with drugs other than nitroimidazoles can be attempted, but cure rates are low (<50%) 3
- High-dose intravaginal metronidazole combined with miconazole has shown promise in small studies (80% efficacy) but is not standard of care 9
HIV Infection
Common Pitfalls and Caveats
- Failure to treat sexual partners is a common cause of recurrent infection 1, 10
- Metronidazole resistance is emerging and should be considered in cases of treatment failure 7
- Trichomoniasis is associated with adverse pregnancy outcomes and increased HIV transmission risk 10
- Asymptomatic infection is common in both men and women, highlighting the importance of screening high-risk individuals 10